{"id":446338,"date":"2023-05-14T15:19:00","date_gmt":"2023-05-14T13:19:00","guid":{"rendered":"https:\/\/innovationorigins.com\/?p=446338"},"modified":"2023-05-14T15:19:00","modified_gmt":"2023-05-14T13:19:00","slug":"delta-diagnostics-raises-e5-25-million-in-series-a-funding-to-revolutionize-biosensing-technology","status":"publish","type":"post","link":"https:\/\/ioplus.nl\/archive\/en\/delta-diagnostics-raises-e5-25-million-in-series-a-funding-to-revolutionize-biosensing-technology\/","title":{"rendered":"Delta Diagnostics raises \u20ac5.25 million in Series A Funding to Revolutionize Biosensing Technology"},"content":{"rendered":"\n<p><a href=\"https:\/\/bit.ly\/3LVaVbs\">Delta Diagnostics<\/a>, a Dutch start-up in label-free, multiplexed biosensing, has secured Series A funding of \u20ac5.25 million.\u00a0The round was funded by a consortium of four investors:\u00a0<a href=\"https:\/\/www.inibio.eu\/\">i&amp;i Biotech Fund<\/a>,\u00a0<a href=\"http:\/\/oost.nl\">Oost NL<\/a>,\u00a0<a href=\"https:\/\/www.innovationquarter.nl\/\">InnovationQuarter<\/a>,\u00a0and\u00a0<a href=\"https:\/\/www.photondelta.com\/photondelta\/\">PhotonDelta<\/a>. The investment aims to fuel the company\u2019s vision of making rapid, sensitive, and low-cost biosensors accessible to all.\u00a0<\/p>\n\n\n\n<p><a rel=\"noreferrer noopener\" href=\"https:\/\/bit.ly\/3LVaVbs\" target=\"_blank\">Delta Diagnostics<\/a>\u00a0is a TNO spin-off that simplifies biosensing, and the detection of biomolecules, using photonic integrated circuits. This cost-effective method accelerates Life Sciences research and enables multiplexing to analyze multiple biomolecules simultaneously.\u00a0<\/p>\n\n\n\n<p>Bart de Boer, CTO of Delta Diagnostics: \u201cToday\u2019s scientists need more answers, faster. We create highly-sensitive label-free biosensing instruments enabling our customers to accelerate their research tremendously.\u201d\u00a0<\/p>\n\n\n\n<p>\u201cSecuring Series A funding marks a significant milestone for Delta Diagnostics, validating our technology and our vision to create multiplexed biosensing,\u201d says Guy Dewil, CEO of Delta Diagnostics. \u201cWe are grateful to our investors for their support and strongly believe in our mission. This investment will accelerate the launch of our first product. It will unlock the full potential of our biosensing technology to drive discoveries in Life Sciences.\u201d&nbsp;&nbsp;<\/p>\n\n\n\n<p>\u201cWe are thrilled to accompany Delta Diagnostics in developing such a promising cutting-edge biosensing technology for the industry and academic research,\u201d says Karel Kubias, Partner at i&amp;i Biotech Fund. &#8220;We firmly believe that Delta\u00b4s technology can effectively improve the biosensing arena significantly.&#8221; \u00a0<\/p>\n\n\n\n<p>With\u00a0<a rel=\"noreferrer noopener\" href=\"https:\/\/www.tno.nl\/en\/newsroom\/2022\/07\/cash-infusion-for-photonics-startup\/\" target=\"_blank\">initial funding<\/a>\u00a0from TNO and UNIQ, the company has grown into an experienced team. The Series A funding will propel the company forward as its first product launch approaches. This will enable the company and its key partners from the Overijssel region to further develop next-generation biosensor systems for real-time biomolecule detection in samples.\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Delta Diagnostics, a Dutch start-up in label-free, multiplexed biosensing, has secured Series A funding of \u20ac5.25 million.\u00a0The round was funded by a consortium of four investors:\u00a0i&amp;i Biotech Fund,\u00a0Oost NL,\u00a0InnovationQuarter,\u00a0and\u00a0PhotonDelta. The investment aims to fuel the company\u2019s vision of making rapid, sensitive, and low-cost biosensors accessible to all.\u00a0 Delta Diagnostics\u00a0is a TNO spin-off that simplifies biosensing, [&hellip;]<\/p>\n","protected":false},"author":2589,"featured_media":495159,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[34665],"tags":[58838],"location":[6763],"article_type":[36684],"serie":[],"archives":[],"internal_archives":[],"reboot-archive":[],"class_list":["post-446338","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-delta-diagnostics","location-netherlands","article_type-news"],"blocksy_meta":[],"acf":{"subtitle":"\u201cToday\u2019s scientists need more answers, faster. We create highly-sensitive label-free biosensing instruments enabling our customers to accelerate their research tremendously.\u201d","text_display_homepage":false},"author_meta":{"display_name":"Team IO","author_link":"https:\/\/ioplus.nl\/archive\/author\/erikdevries\/"},"featured_img":"https:\/\/ioplus.nl\/archive\/wp-content\/uploads\/2023\/05\/Delta_Diagnostics_15_1200px.jpg","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/ioplus.nl\/archive\/en\/category\/health\/\" class=\"advgb-post-tax-term\">Health<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Health<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/ioplus.nl\/archive\/en\/category\/health\/\" class=\"advgb-post-tax-term\">Delta Diagnostics<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Delta Diagnostics<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 3 years ago","modified":"Updated 3 years ago"},"absolute_dates":{"created":"Posted on May 14, 2023","modified":"Updated on May 14, 2023"},"absolute_dates_time":{"created":"Posted on May 14, 2023 3:19 pm","modified":"Updated on May 14, 2023 3:19 pm"},"featured_img_caption":"","series_order":"","_links":{"self":[{"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/posts\/446338","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/users\/2589"}],"replies":[{"embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/comments?post=446338"}],"version-history":[{"count":0,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/posts\/446338\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/media\/495159"}],"wp:attachment":[{"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/media?parent=446338"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/categories?post=446338"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/tags?post=446338"},{"taxonomy":"location","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/location?post=446338"},{"taxonomy":"article_type","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/article_type?post=446338"},{"taxonomy":"serie","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/serie?post=446338"},{"taxonomy":"archives","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/archives?post=446338"},{"taxonomy":"internal_archives","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/internal_archives?post=446338"},{"taxonomy":"reboot-archive","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/reboot-archive?post=446338"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}